| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0019 | 1 |